Commissioner Califf's Comments On Supplement Testing Trouble NPA
This article was originally published in The Tan Sheet
Executive Summary
NPA notes a 2010 comment that an omega-3 fish oil study "may be a lesson of all this food supplement stuff that we need to test them like drugs.” Senator Hatch asks Califf to reign in FDA's practice of using guidances to impose additional rules.
You may also be interested in...
Supplement NDI Draft Guidance Discussions Snagged On Basic Criteria
FDA’s dietary supplement division is concerned that firms are not submitting NDI notifications in cases where they should be, while industry stakeholders assert the agency needs to clarify the criteria for determining which products should be the subject of notifications and what information is needed.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.